Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00126490
Status:
COMPLETED
Last Update Posted:
2015-06-30
First Post:
2005-08-02
Brief Title:
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Renal Cell Cancer |
| Recurrent Renal Cell Carcinoma |
Keywords: